دورية أكاديمية
أعرض في EDS

COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil.

التفاصيل البيبلوغرافية
العنوان: COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil.
المؤلفون: Nery N Jr; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil., Ticona JPA; Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil., Cardoso CW; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Secretaria Municipal de Saúde de Salvador, Salvador, Brazil., Prates APPB; Secretaria Municipal de Saúde de Salvador, Salvador, Brazil., Vieira HCA; Secretaria Municipal de Saúde de Salvador, Salvador, Brazil., Salvador de Almeida A; Secretaria Municipal de Saúde de Salvador, Salvador, Brazil., Souza MMDS; Secretaria Municipal de Saúde de Salvador, Salvador, Brazil., Borba Dos Reis O; Secretaria Municipal de Saúde de Salvador, Salvador, Brazil., Pellizzaro M; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil., Portilho MM; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Rosa da Anunciação R; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Victoriano R; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Oliveira Dos Anjos R; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Argibay HD; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Carmo Lima DO; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Mesquita IL; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Conceição WM; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Santana PM; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Oliveira EC; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Santana PSN; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Brodskyn CI; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Mothé Fraga DB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Escola de Medicina Veterinária e Zootecnia, Universidade Federal da Bahia, Salvador, Brazil., Solcà MDS; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Escola de Medicina Veterinária e Zootecnia, Universidade Federal da Bahia, Salvador, Brazil., Reis MG; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.; Yale School of Public Health, New Haven, CT, United States of America., Costa F; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil.; Yale School of Public Health, New Haven, CT, United States of America., Ribeiro GS; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.
المصدر: PloS one [PLoS One] 2022 Jan 21; Vol. 17 (1), pp. e0262649. Date of Electronic Publication: 2022 Jan 21 (Print Publication: 2022).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: COVID-19/*prevention & control , COVID-19 Vaccines/*administration & dosage , SARS-CoV-2/*pathogenicity , Vaccination/*psychology , Vaccination Hesitancy/*psychology, Adult ; Aged ; Brazil/epidemiology ; COVID-19/epidemiology ; Cross-Sectional Studies ; Female ; Humans ; Intention ; Male ; Middle Aged ; Multivariate Analysis ; SARS-CoV-2/immunology ; Sex Factors ; Vaccination/statistics & numerical data ; Vaccination Hesitancy/statistics & numerical data
مستخلص: Vaccination is a major strategy to prevent the coronavirus disease 2019 (COVID-19). However, information about factors associated with men and women intention to be vaccinated are scarce. To determine COVID-19 vaccine acceptance and identify factors associated vaccine hesitancy according to sex, we performed a cross-sectional population-based random survey in Salvador, Brazil between Nov/2020-Jan/2021. Participants were interviewed to obtain data on intention to receive and pay for a COVID-19 vaccine, as well as on demographics, comorbidities, influenza vaccination history, previous diagnosis of COVID-19, and exposures and perception of COVID-19 risk. Among 2,521 participants, 2,053 (81.4%) reported willingness to use a COVID-19 vaccine and 468 (18.6%) hesitated to take it. Among those intending to get vaccinated, 1,400 (68.2%) would pay for the vaccine if necessary. Sex-stratified multivariable analysis found that men who were working and who had comorbidities were less likely to hesitate about using the vaccine. Among women, higher educational level and high perception of COVID-19 risk were associated with less vaccine hesitancy. In both groups, reporting influenza vaccination in 2020 reduced the chance of COVID-19 vaccine hesitancy. COVID-19 vaccine campaigns targeting to reduce vaccine hesitancy are urgently needed. These campaigns should consider gender differences in order to be successful.
Competing Interests: The authors have declared that no competing interests exist.
References: Eur J Epidemiol. 2020 Aug;35(8):775-779. (PMID: 32785815)
Lancet. 2021 Jan 30;397(10272):361. (PMID: 33516326)
Vaccines (Basel). 2020 Dec 30;9(1):. (PMID: 33396832)
Nat Med. 2021 Feb;27(2):225-228. (PMID: 33082575)
Lancet Public Health. 2021 Jun;6(6):e353-e354. (PMID: 33991483)
SN Compr Clin Med. 2020;2(8):1069-1076. (PMID: 32838147)
JAMA Health Forum. 2020 Sep 1;1(9):e201061. (PMID: 36218727)
PLoS One. 2021 Jan 22;16(1):e0245859. (PMID: 33481945)
Lancet. 2020 Feb 29;395(10225):676. (PMID: 32113495)
Soc Sci Med. 2021 Jul;281:114093. (PMID: 34144480)
Rev Soc Bras Med Trop. 2020 Dec 21;54:e07132020. (PMID: 33338115)
J Infect Public Health. 2020 Dec;13(12):1833-1839. (PMID: 32788073)
Psychol Med. 2022 Oct;52(14):3127-3141. (PMID: 33305716)
PLoS One. 2016 Oct 21;11(10):e0164541. (PMID: 27768704)
J Infect Public Health. 2020 Feb;13(2):211-215. (PMID: 31431425)
Vaccine. 2011 Sep 2;29(38):6472-84. (PMID: 21756960)
Lancet Public Health. 2021 Jun;6(6):e416-e427. (PMID: 33991482)
Prev Med. 2012 May;54(5):358-62. (PMID: 22465670)
Data (Basel). 2021 Jun;6(6):. (PMID: 34504894)
Nat Med. 2021 Jul;27(7):1230-1238. (PMID: 34035535)
JAMA. 2020 May 12;323(18):1775-1776. (PMID: 32203977)
Vaccines (Basel). 2021 Aug 26;9(9):. (PMID: 34579188)
PLoS One. 2015 Apr 13;10(4):e0123840. (PMID: 25874953)
Lancet. 2019 Jul 27;394(10195):345-356. (PMID: 31303318)
المشرفين على المادة: 0 (COVID-19 Vaccines)
تواريخ الأحداث: Date Created: 20220121 Date Completed: 20220201 Latest Revision: 20231103
رمز التحديث: 20231103
مُعرف محوري في PubMed: PMC8782400
DOI: 10.1371/journal.pone.0262649
PMID: 35061811
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0262649